Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards

Arja ter Elst; Nils A. 't Hart; Anthonie J. van der Wekken; Wim Timens; Lucie B. Hijmering-Kappelle; Geke A. Hospers; Hilde Jalving; Elise M. van der Logt; Leon C. van Kempen; Sjoukje F. Oosting; Matthew R. Groves; T. Jeroen Hiltermann; Anke van den Berg; Harry J. Groen; Ed Schuuring

doi:10.1158/1538-7445.AM2017-754

Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards

Arja ter Elst, Nils A. 't Hart, Anthonie J. van der Wekken, Wim Timens, Lucie B. Hijmering-Kappelle, Geke A. Hospers, Hilde Jalving, Elise M. van der Logt, Leon C. van Kempen, Sjoukje F. Oosting, Matthew R. Groves, T. Jeroen Hiltermann, Anke van den Berg, Harry J. Groen, Ed Schuuring

Onderzoeksoutput › Academic

Originele taal-2	English
Artikelnummer	Abstract 754
Aantal pagina's	2
Tijdschrift	Cancer Research
Volume	77
DOI's	https://doi.org/10.1158/1538-7445.AM2017-754
Status	Published - jul.-2017
Evenement	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Washington Duur: 1-apr.-2017 → 5-apr.-2017

Toegang tot document

10.1158/1538-7445.AM2017-754

Handle.net

Permanente koppeling

Citeer dit

ter Elst, A., 't Hart, N. A., van der Wekken, A. J., Timens, W., Hijmering-Kappelle, L. B., Hospers, G. A., Jalving, H., van der Logt, E. M., van Kempen, L. C., Oosting, S. F., Groves, M. R., Hiltermann, T. J., van den Berg, A., Groen, H. J., & Schuuring, E. (2017). Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards. Cancer Research, 77, Artikel Abstract 754. https://doi.org/10.1158/1538-7445.AM2017-754

@article{926bd0f3d83c4c8a96c8d193e9c0fbd1,

title = "Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards",

author = "{ter Elst}, Arja and {'t Hart}, {Nils A.} and {van der Wekken}, {Anthonie J.} and Wim Timens and Hijmering-Kappelle, {Lucie B.} and Hospers, {Geke A.} and Hilde Jalving and {van der Logt}, {Elise M.} and {van Kempen}, {Leon C.} and Oosting, {Sjoukje F.} and Groves, {Matthew R.} and Hiltermann, {T. Jeroen} and {van den Berg}, Anke and Groen, {Harry J.} and Ed Schuuring",

year = "2017",

month = jul,

doi = "10.1158/1538-7445.AM2017-754",

language = "English",

volume = "77",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "AMER ASSOC CANCER RESEARCH",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 01-04-2017 Through 05-04-2017",

}

ter Elst, A, 't Hart, NA, van der Wekken, AJ , Timens, W , Hijmering-Kappelle, LB , Hospers, GA , Jalving, H, van der Logt, EM, van Kempen, LC , Oosting, SF , Groves, MR , Hiltermann, TJ , van den Berg, A , Groen, HJ & Schuuring, E 2017, 'Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards: A role for multidisciplinary molecular tumor boards', Cancer Research, vol. 77, Abstract 754. https://doi.org/10.1158/1538-7445.AM2017-754

TY - JOUR

T1 - Treatment decision-making of rare ERBB2 (HER2) mutations in lung cancer; a role for multidisciplinary molecular tumor boards

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

AU - ter Elst, Arja

AU - 't Hart, Nils A.

AU - van der Wekken, Anthonie J.

AU - Timens, Wim

AU - Hijmering-Kappelle, Lucie B.

AU - Hospers, Geke A.

AU - Jalving, Hilde

AU - van der Logt, Elise M.

AU - van Kempen, Leon C.

AU - Oosting, Sjoukje F.

AU - Groves, Matthew R.

AU - Hiltermann, T. Jeroen

AU - van den Berg, Anke

AU - Groen, Harry J.

AU - Schuuring, Ed

PY - 2017/7

Y1 - 2017/7

U2 - 10.1158/1538-7445.AM2017-754

DO - 10.1158/1538-7445.AM2017-754

M3 - Meeting Abstract

SN - 0008-5472

VL - 77

JO - Cancer Research

JF - Cancer Research

M1 - Abstract 754

Y2 - 1 April 2017 through 5 April 2017

ER -